|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 16, 2005 J. Lipid Res., doi:10.1194/jlr.D400034-JLR200
Molecular Celbiology, Farmacology, Katholieke Universiteit Leuven, Leuven, Vlaams-Brabant 3000
Corresponding Author: helena.vanoverloop{at}med.kuleuven.ac.be
Upon exposure of truncated ceramides, such as N-acetyl-sphingenine, and long chain ceramides to moderate acidic conditions, three derivatives are formed. Two of them turned out to be O-acylated sphingenine, 1-O- and 3-O-acyl-sphingenine, the other was identified as sphingenine. Also truncated dihydroceramides, e.g. N-acetyl- and N-hexanoyl-sphinganine, show this type of rearrangement, which is therefore not related to the presence of the allylic hydroxy group or to the length of the N-acyl chain. Of particular concern is the fact that the O-acylated compounds, which can be considered as sphingoid base analogues, can be formed in chloroform or chloroform/methanol mixtures upon storage. For long term storage, methanol or dichloromethane are preferred solvents. A procedure to document the presence/formation of such O-acylated sphingoid bases in (dihydro)ceramide solutions in the pmol range, based on reversed phase chromatography after derivatization of their amino group with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, is presented.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||